Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Adma Biologics (NQ: ADMA ) 19.77 -0.22 (-1.10%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,704,451 Open 19.93 Bid (Size) 19.60 (3) Ask (Size) 19.70 (6) Prev. Close 19.99 Today's Range 19.40 - 20.06 52wk Range 3.060 - 20.37 Shares Outstanding 196,357,149 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Looking for growth without the hefty price tag? Consider NASDAQ:ADMA. September 24, 2024 Looking for growth without the hefty price tag? Consider NASDAQ:ADMA. Via Chartmill In-Depth Examination Of 4 Analyst Recommendations For ADMA Biologics September 20, 2024 Via Benzinga Performance YTD +334.51% +334.51% 1 Month +19.31% +19.31% 3 Month +73.42% +73.42% 6 Month +206.99% +206.99% 1 Year +460.06% +460.06% More News Read More ADMA Biologics Set to Join S&P SmallCap 600 Index September 17, 2024 From ADMA Biologics, Inc. Via GlobeNewswire ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference September 10, 2024 From ADMA Biologics, Inc. Via GlobeNewswire Assessing ADMA Biologics: Insights From 4 Financial Analysts August 12, 2024 Via Benzinga What's Going On With ADMA Biologics Stock Monday? September 09, 2024 Via Benzinga Topics Stocks Exposures US Equities Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday September 09, 2024 Via Benzinga Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark September 05, 2024 Via Investor's Business Daily 'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics August 30, 2024 Via Benzinga Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers August 29, 2024 Via Investor's Business Daily Biohaven Stock Earns Relative Strength Rating Upgrade August 21, 2024 Via Investor's Business Daily SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating August 21, 2024 Via Investor's Business Daily Immunome Stock Sees RS Rating Jump To 91 August 20, 2024 Via Investor's Business Daily PTC Therapeutics Stock Earns RS Rating Upgrade To 83 August 19, 2024 Via Investor's Business Daily 10 Health Care Stocks Whale Activity In Today's Session August 19, 2024 Via Benzinga ADMA Biologics Announces Partial Paydown of Revolving Credit Facility August 14, 2024 From ADMA Biologics, Inc. Via GlobeNewswire Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio? August 11, 2024 Via Benzinga Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday August 09, 2024 Via Benzinga ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 Via InvestorPlace ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update August 08, 2024 From ADMA Biologics, Inc. Via GlobeNewswire Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82 August 06, 2024 Via Investor's Business Daily ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024 August 01, 2024 From ADMA Biologics, Inc. Via GlobeNewswire Vir Biotechnology Stock Reaches 80-Plus RS Rating Benchmark July 26, 2024 Via Investor's Business Daily Beam Therapeutics Stock Earns RS Rating Jump To 85 July 24, 2024 Via Investor's Business Daily Jim Cramer Recommends Not Selling Vertiv, Says Buy This Social Media Stock 'Hand Over Fist' July 23, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.